Dr. Grilley-Olson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Duke Cancer Center
20 Duke Medicine Cir
Durham, NC 27710Phone+1 919-613-5550- Is this information wrong?
Summary
- Dr. Juneko Grilley-Olson is an oncologist in Durham, NC and is affiliated with Duke University. She received her medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 14 years. She specializes in sarcoma, and developmental therapeutics.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2006 - 2009
Hennepin HealthcareResidency, Internal Medicine, 2003 - 2006
University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
NC State Medical License 2006 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
- BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29
- Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsPhase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Th...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
- 1 citationsA League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.Laurie Graves, William R Jeck, Juneko E Grilley-Olson> ;Current Treatment Options in Oncology. 2023 Mar 1
- 4 citationsA Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.Cherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, Olivier Harismendy, José M Flores, Tara Moore-Medlin, Everett E Vokes, J Silvio Gutkind, Prakash Neupane, Glenn M...> ;Clinical Cancer Research. 2022 Dec 1
- Join now to see all
Press Mentions
Largest-Ever Precision Medicine Oncology Trial Ready for LaunchJune 1st, 2015
Professional Memberships
- Member
Hospital Affiliations
Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
